Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.
Nancy M McClungJulia W GarganoNancy M BennettLinda M NiccolaiNasreen AbdullahMarie R GriffinIna U ParkAngela A ClevelandTroy D QuerecElizabeth R UngerLauri E Markowitznull nullPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
The declining proportion of HPV16/18-positive CIN2+ provides additional evidence of vaccine impact in the United States.
Keyphrases